IHH Healthcare Berhad (IHH) is one of the largest listed private healthcare providers in the world based on market capitalisation, with a focus on markets in Asia and the CEEMENA region.
IHH operates an integrated healthcare business and related services which have leading market positions in its home markets of Singapore, Malaysia and Turkey. It also has healthcare operations and investments in China, India, Hong Kong, Vietnam, Brunei and Macedonia.
IHH's global healthcare network operates over 4,900 licensed beds in 30 hospitals, as well as 60 medical centres, clinics and ancillary healthcare businesses across eight countries. In addition, it has over 3,300 new beds in the pipeline to be delivered through new hospital developments and expansion of its existing facilities over the next five years, which includes two potential hospital development projects in Turkey. These new beds in the pipeline also include approximately 760 new beds over the next five years, which will be managed through hospital management agreements.
IHH’s core businesses are operated through its key subsidiaries, namely Parkway Pantai Limited (PPL), Acibadem Holding and IMU Health.
PPL is the holding company for IHH’s integrated Parkway and Pantai healthcare businesses in Singapore and Malaysia respectively, with investments and operations in China and Hong Kong, India, Vietnam and Brunei.
Acibadem Holding owns Acibadem, an integrated private healthcare and diagnostics provider with an extensive network across Turkey and a leading player in the Turkish private healthcare sector.
IMU Health operates IMU, a private university based in Malaysia offering medical, dental, pharmacy, nursing, health science and complementary medicine programmes. It was Malaysia's first private healthcare university to offer local and foreign programmes.